Our people and capital support charitable organizations in the emerging markets where we work and live. Through our Annual Charity Day, we support programs focused on small business development, economic empowerment, education and environmental initiatives.
Every two minutes a child dies from malaria, and yet it can be prevented with mosquito nets that cost as little as £5 to buy, deliver and hang, and treatment that costs less than £1. Malaria No More UK believes that no child should die from a malaria mosquito bite and is building support to end malaria within a generation.
For more info visit: www.malarianomore.org.uk or follow on social media @malarianomoreuk
Founded in 2000 on the belief that World Change Starts with Educated Children®, Room to Read’s innovative model focuses on deep, systemic transformation within schools in low-income countries during two time periods which are most critical in a child’s schooling: early primary school for literacy acquisition and secondary school for girls’ education.
We work in collaboration with local communities, partner organizations and governments to develop literacy skills and a habit of reading among primary school children and ensure girls can complete secondary school with the skills necessary to negotiate key life decisions. Room to Read has benefited 10 million children across 18,000 communities in Asia and Africa and aims to reach 15 million children by 2020. Learn more at www.roomtoread.org.
The Sohana Research Fund exists to fund promising research projects and clinical trials that aim to lead to effective treatments and ultimately a cure for Recessive Dystrophic Epidermolysis Bullosa ("RDEB") and other forms for EB. This is a genetic skin condition that leads to blistering and skin loss at the slightest friction. It is "Hard to say. Hell to live with" and children with the condition live in constant pain associated with the burn like wounds that occur.
The intense pain and repeated damage leads to progressive disability and severe forms are life shortening due to a malignant skin cancer that develops in early adulthood. There is now real hope of treatments and even a cure for RDEB and the Sohana Research Fund aims to help translate positive findings rapidly to the clinic. SRF is primarily investing in cell and gene therapy research and have just funded a world first gene therapy trial in adults. Our current priorities include a gene therapy trial in children and gene editing projects. The Sohana Research Fund was founded and is run by parents of a young sufferer and is a UK registered charity no 1158672.
Learn More at: www.sohanaresearchfund.org
Exotix will be raising money for 275 street-children affected by the AIDS epidemic in Mozambique. Over the coming year, the funds will enable the children, many of whom are HIV+, to sleep in a safe place, wash, enjoy a hot meal and access vital health-care. 20 of the children will be re-integrated with their families and helped back into education. The Egmont Trust is a UK registered charity that supports projects across 6 countries in sub-Saharan African working to reduce the impact of HIV & AIDS on vulnerable children.
Learn More at: www.egmonttrust.org
Exotix Partners LLP is authorised and regulated by the Financial Conduct Authority (FCA).
Exotix USA, Inc. is a U.S. registered broker dealer and a member of FINRA & SIPC.
Click here for the BCP Disclosure Statement